Sakar Healthcare Ltd (SAKAR) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 1002668, "name": "Sakar Healthcare", "stock_name": "Sakar Healthcare", "full_name": "Sakar Healthcare Ltd", "name_url": "stocks-analysis/sakar-healthcare", "exchange": 1, "exchangecode": "", "primexch": 1, "country_id": 34, "currency": "INR", "cmp": "839.10", "chg": 15, "chgp": "1.82%", "dir": 1, "prev_price": "824.10", "mcapval": "1,866.99 Cr", "mcap": "Micro Cap", "scripcode": "", "symbol": "SAKAR", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "sector_id": 65, "indexname": "India SENSEX", "isin": "INE732S01012", "curr_date": "Jun 15, 01:26 PM", "curr_time": "13:44 PM", "last_traded_at": "Jun 15, 01:26 PM IST", "bse_nse_vol": 66633, "exc_status": "Active", "traded_date": "Jun 15, 2026", "traded_date_str": "2026 06 15", "score": "", "scoreText": "", "Live": 0, "market_time": 1, "is_blur": 1, "is_blur_class": "blur-register-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/sakar-healthcare-1002668-1&utm_source=Spage_Header_Score", "mojoone": { "text": "Part of MojoOne Strategy", "type": "MN", "url": "https://www.marketsmojo.com/mojopro/strategy/2", "ismore": 0, "all_data": [], "is_blur": 1, "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/sakar-healthcare-1002668-1&utm_source=Spage_Score_PartofStrategies" } }, "news": { "results": [ { "title": "Sakar Healthcare Ltd is Rated Buy", "link": "https://www.marketsmojo.com/news/stock-recommendation/sakar-healthcare-ltd-is-rated-buy-4037095", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/SakarHealthcare_mojoScore_4037095.png", "date": "2026-06-06 10:10:33", "description": "Sakar Healthcare Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 15 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 08 June 2026, providing investors with the most up-to-date view of the company’s performance and outlook." }, { "title": "Sakar Healthcare Ltd is Rated Buy", "link": "https://www.marketsmojo.com/news/stock-recommendation/sakar-healthcare-ltd-is-rated-buy-4037060", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/SakarHealthcare_mojoScore_4037060.png", "date": "2026-06-05 10:10:38", "description": "Sakar Healthcare Ltd is rated Buy by MarketsMOJO, with this rating last updated on 15 May 2026. While the rating change occurred on that date, the analysis and financial metrics discussed here reflect the stock’s current position as of 08 June 2026, providing investors with the most up-to-date view of the company’s fundamentals and market performance." }, { "title": "Sakar Healthcare Ltd Locks at Upper Circuit With 6.89% Gain — Buyers Queue, Sellers Absent", "link": "https://www.marketsmojo.com/news/stocks-in-action/sakar-healthcare-ltd-surges-to-upper-circuit-on-robust-buying-momentum-4010727", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/SakarHealthcare_stocks_hitting_upper_circuit_4010727.png", "date": "2026-05-25 11:00:53", "description": "At Rs 837.75, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Sakar Healthcare Ltd locked at its upper circuit of 10% on 25 May 2026, with buyers queuing and no sellers willing to part with shares." }, { "title": "Sakar Healthcare Ltd is Rated Buy", "link": "https://www.marketsmojo.com/news/stock-recommendation/sakar-healthcare-ltd-is-rated-buy-4010214", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/SakarHealthcare_mojoScore_4010214.png", "date": "2026-05-25 10:10:41", "description": "Sakar Healthcare Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 15 May 2026. While the rating was revised on that date, the analysis and financial metrics presented here reflect the stock’s current position as of 25 May 2026, providing investors with the latest insights into its performance and outlook." }, { "title": "143% Stock Return vs 91% Profit Growth: What Drives Sakar Healthcare Ltd’s Multibagger Rally?", "link": "https://www.marketsmojo.com/news/stocks-in-action/sakar-healthcare-ltd-delivers-multibagger-returns-amid-robust-financial-performance-3996458", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/SakarHealthcare_multibagger_3996458.png", "date": "2026-05-18 09:50:04", "description": "A 143.23% stock return in one year. A 91.32% growth in net profit over the same period. The gap between those two numbers — roughly 52 percentage points — is driven by the market’s willingness to pay more for each rupee of Sakar Healthcare Ltd’s earnings. That willingness is the story behind this micro-cap’s multibagger status." }, { "title": "Sakar Healthcare Gains 27.72%: 4 Key Factors Driving the Week’s Surge", "link": "https://www.marketsmojo.com/news/stocks-in-action/sakar-healthcare-gains-2772-4-key-factors-driving-the-weeks-surge-3994320", "imagepath": "", "date": "2026-05-16 13:04:30", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>11 May:</strong> Stock opens at Rs.529.60, down 2.91% amid market weakness</p>\n <p><strong>12 May:</strong> Surges to upper circuit at Rs.635.50 on robust buying momentum</p>\n <p><strong>13 May:</strong> Reports stellar Q4 FY26 results; technical momentum shifts bullish</p>\n <p><strong>15 May:</strong> Closes week at Rs.696.70, up 16.16% on heavy volume</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.545.50</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</d..." }, { "title": "Sakar Healthcare Ltd is Rated Buy", "link": "https://www.marketsmojo.com/news/stock-recommendation/sakar-healthcare-ltd-is-rated-buy-3991113", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/SakarHealthcare_mojoScore_3991113.png", "date": "2026-05-14 10:10:03", "description": "Sakar Healthcare Ltd is rated Buy by MarketsMOJO, with this rating last updated on 14 May 2026. While the rating change occurred on this date, the analysis and financial metrics discussed here reflect the stock's current position as of 14 May 2026, providing investors with an up-to-date view of the company’s standing." }, { "title": "Are Sakar Healthcare Ltd latest results good or bad?", "link": "https://www.marketsmojo.com/news/result-analysis/are-sakar-healthcare-ltd-latest-results-good-or-bad-3989974", "imagepath": "", "date": "2026-05-13 19:20:25", "description": "Sakar Healthcare Ltd's latest financial results for the quarter ended March 2026 demonstrate notable operational performance, characterized by substantial year-on-year growth across key metrics. The company reported a net profit of ₹11.02 crores, reflecting a significant increase of 91.32% compared to the same quarter last year. This growth in net profit was accompanied by a revenue of ₹71.10 crores, which also showed a robust year-on-year increase of 41.52%. \n\nThe operating margin, excluding other income, reached 36.91%, marking the highest level in the company's recent history and indicating effective cost management and operational efficiency. This margin expansion of 560 basis points from the previous year underscores the company's ability to scale revenues while controlling expenses. Additionally, the profit before tax surged to ₹18.06 crores, up 64.90% quarter-on-quarter and 189.42% year-on-year, driv..." }, { "title": "Sakar Healthcare Q4 FY26: Stellar Quarter Masks Valuation Concerns", "link": "https://www.marketsmojo.com/news/result-analysis/sakar-healthcare-q4-fy26-stellar-quarter-masks-valuation-concerns-3989526", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/SakarHealthcare_quaterlyResult_3989526.png", "date": "2026-05-13 09:53:06", "description": "Sakar Healthcare Ltd., a Gujarat-based pharmaceutical company, delivered an exceptional fourth quarter for FY26, reporting net profit of ₹11.02 crores—a robust 91.32% surge year-on-year and a 7.51% sequential improvement from December quarter's ₹10.25 crores. The micro-cap pharma player, with a market capitalisation of ₹1,330.10 crores, demonstrated remarkable operational momentum as revenue climbed to ₹71.10 crores, marking a 41.52% year-on-year expansion and modest 1.08% quarter-on-quarter growth." } ], "total": 407, "sid": "1002668", "stock_news_url": "https://www.marketsmojo.com/news/sakar-healthcare-1002668" }, "announcements": [ { "details": "Sakar Healthcare Limitedealthcare Limited for the quarter ended 30-Sep-2019 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.", "source": "NSE", "caption": "Sakar Healthcare Limited - Reply to Clarification- Financial results", "datetime": "09-Dec-2019" }, { "details": "Sakar Healthcare Limitede Limited for the quarter ended 30-Sep-2019 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.", "source": "NSE", "caption": "Sakar Healthcare Limited - Clarification - Financial Results", "datetime": "03-Dec-2019" }, { "details": "Sakar Healthcare Limited has informed the Exchange regarding Board meeting held on November 14, 2019.", "source": "NSE", "caption": "Sakar Healthcare Limited - Outcome of Board Meeting", "datetime": "14-Nov-2019" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "No <strong>Dividend</strong> history available", "data": [] }, { "img": "splits.svg", "title": "SPLITS", "msg": "No <strong>Splits</strong> history available", "data": [] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

11 May: Stock opens at Rs.529.60, down 2.91% amid market weakness

12 May: Surges to upper circuit at Rs.635.50 on robust buying momentum

13 May: Reports stellar Q4 FY26 results; technical momentum shifts bullish

15 May: Closes week at Rs.696.70, up 16.16% on heavy volume

Week Open

Rs.545.50

Week CloseRead full news article

Sakar Healthcare Ltd is Rated Buy

2026-05-14 10:10:03

Sakar Healthcare Ltd is rated Buy by MarketsMOJO, with this rating last updated on 14 May 2026. While the rating change occurred on this date, the analysis and financial metrics discussed here reflect the stock's current position as of 14 May 2026, providing investors with an up-to-date view of the company’s standing.

Read full news article

Are Sakar Healthcare Ltd latest results good or bad?

2026-05-13 19:20:25

Sakar Healthcare Ltd's latest financial results for the quarter ended March 2026 demonstrate notable operational performance, characterized by substantial year-on-year growth across key metrics. The company reported a net profit of ₹11.02 crores, reflecting a significant increase of 91.32% compared to the same quarter last year. This growth in net profit was accompanied by a revenue of ₹71.10 crores, which also showed a robust year-on-year increase of 41.52%. The operating margin, excluding other income, reached 36.91%, marking the highest level in the company's recent history and indicating effective cost management and operational efficiency. This margin expansion of 560 basis points from the previous year underscores the company's ability to scale revenues while controlling expenses. Additionally, the profit before tax surged to ₹18.06 crores, up 64.90% quarter-on-quarter and 189.42% year-on-year, driv...

Read full news article

Sakar Healthcare Q4 FY26: Stellar Quarter Masks Valuation Concerns

2026-05-13 09:53:06

Sakar Healthcare Ltd., a Gujarat-based pharmaceutical company, delivered an exceptional fourth quarter for FY26, reporting net profit of ₹11.02 crores—a robust 91.32% surge year-on-year and a 7.51% sequential improvement from December quarter's ₹10.25 crores. The micro-cap pharma player, with a market capitalisation of ₹1,330.10 crores, demonstrated remarkable operational momentum as revenue climbed to ₹71.10 crores, marking a 41.52% year-on-year expansion and modest 1.08% quarter-on-quarter growth.

Read full news article